Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Comment by Jumpinjackfaston Dec 11, 2021 10:50pm
157 Views
Post# 34222535

RE:Wtf?

RE:Wtf?Yes , as of right now Compmete failure on all fronts , nothing but lies from this Lazy and Greedy management in the 6 years these idiots have been in control all they exceeded in was almost a ( Half A Billion Shares ) . Over 2 years ago they stated that they had 3 or 4 partnerships lined up term letters and these dishonest greedy embiciles , stated when they got some cash this year from the Boston Group that they needed more validation , so in other words rubbish scheme . After the massive destruction of shareholders shares on the reverse split they should change the company name to ( Dice Therapies) because everything this rubbish rolls out is C$&P!! . These greedy liars will start financing away and awarding these criminals shares , with nothing done can't even produce a test and they state they ( Can Break The Code ) .
<< Previous
Bullboard Posts
Next >>